Ekso Bionics Holdings Inc (EKSO) USD0.001

Sell:$0.44Buy:$0.45$0.01 (2.79%)

Prices delayed by at least 15 minutes
Sell:$0.44
Buy:$0.45
Change:$0.01 (2.79%)
Prices delayed by at least 15 minutes
Sell:$0.44
Buy:$0.45
Change:$0.01 (2.79%)
Prices delayed by at least 15 minutes

Company Information

About this company

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Key people

Scott G. Davis
Chief Executive Officer, Director
Jerome Wong
Chief Financial Officer, Corporate Secretary
Jason C. Jones
Chief Operating Officer
Mary Ann Cloyd
Independent Director
Corinna E. Lathan
Independent Director
Charles Li
Independent Director
Deborah Lafer Scher
Independent Director
Click to see more

Key facts

  • EPIC
    EKSO
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US2826443010
  • Market cap
    $11.83m
  • Employees
    61
  • Shares in issue
    28.20m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.